ARTIVION, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
ARTIVION, INC. (AORT) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of -$204.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-23.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2021-02-23
- ARTIVION, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2020 was -$204.00K.
- ARTIVION, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2019 was -$1.92M.
- ARTIVION, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2018 was -$2.08M.
- ARTIVION, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2017 was -$2.66M, a 2073.33% decline from fiscal 2016.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month |
|---|---|
| 2020-12-31 | -$204.00K 10-K · filed 2021-02-23 |
| 2019-12-31 | -$1.92M 10-K · filed 2021-02-23 |
| 2018-12-31 | -$2.08M 10-K · filed 2021-02-23 |
| 2017-12-31 | -$2.66M 10-K · filed 2020-02-19 |
| 2016-12-31 | $135.00K 10-K · filed 2019-02-26 |
| 2015-12-31 | $144.00K 10-K · filed 2018-03-09 |
| 2014-12-31 | $63.00K 10-K · filed 2017-02-16 |
| 2013-12-31 | -$29.00K 10-K · filed 2016-02-16 |
| 2012-12-31 | $32.00K 10-K · filed 2015-02-17 |
| 2011-12-31 | $149.00K 10-K · filed 2014-02-21 |
| 2010-12-31 | $334.00K 10-K · filed 2013-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |